A comparison of the effects of oral copjugated equine estrogen and transdermal estradiol-17β combined with an oral progestin on quality of life in postmenopausal women

Maturitas

Volumn 24, Issue 3, 1996, Pages 177-184

  Hilditch, John R ^a   Lewis, Jacqueline ^a   Ross, Alan H ^b   Peter, Alice ^a   Van Maris, Barb ^a   Franssen, Edmée ^c   Charles, Jocelyn ^a   Norton, Peter ^a   Dunn, Earl V ^a  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b Clin Associates in Repro E   (Canada)

^c NONE

Author keywords

Conjugated equine estrogen; Estrogens; Hormone replacement therapy; Menopause; Quality of life; Transdermal estrogen

Indexed keywords

CONJUGATED ESTROGEN; ESTRADIOL; MEDROXYPROGESTERONE ACETATE;

ADULT; ARTICLE; BREAST DISEASE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; FATIGUE; FEMALE; HEADACHE; HORMONE SUBSTITUTION; HUMAN; LIFE EVENT; MAJOR CLINICAL STUDY; MOOD; ORAL DRUG ADMINISTRATION; POSTMENOPAUSE; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; TRANSDERMAL DRUG ADMINISTRATION; VAGINA BLEEDING;

EQUIDAE;

EID: 0030199980     PISSN: 03785122     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5122(96)82007-X     Document Type: Article

References (25)

1. Campbell S, Whitehead M. Estrogen therapy and the menopausal syndrome. Clinics Obstet Gynecol. 4:(1):1977;31-47.
2. Laufer LR, Defazio JL, Lu JKH, et al. Estrogen replacement therapy by transdermal estradiol administration. Am J Obstet Gynecol. 146:1983;533-540.
3. Semmens JP, Wagner G. Estrogen deprivation and vaginal function in postmenopausal women. JAMA. 248:1982;445-448.
4. Erlik Y, Tataryn IV, Meldrum DR, et al. Association of waking episodes with menopausal hot flashes. JAMA. 245:1981;1741-1744.
5. Schiff I, Regestein Q, Tulchinski D, et al. Effects of estrogen on sleep and psychological states of hypogonadal women. JAMA. 242:(22):1979;2405-2407.
6. Padwick ML, Endacott J, Whitehead MI. Efficacy, acceptability and metabolic effects of transdermal estradiol in the management of postmenopausal women. Am J Obstet Gynecol. 152:1991;1085-1091.
7. Place VA, Powers M, Darley PE, Schenkel L, Good WR. A double blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms. Am J Obstet Gynecol. 152:1985;1092-1099.
8. Chetkowski RJ, Meldrum DR, Steingold KA, et al. Biological effects of transdermal estradiol. N Eng J Med. 314:1986;1615-1620.
9. Lindsay R, Hart DM, Clark DM. The minimum effective dose of estrogen for prevention of postmenopausal bone loss. Obstet Gynecol. 63:(6):1984;759-763.
10. Ribot C, Tremollieres F, Pouilles JM, Louvet JP, Peyron R. Preventive effects of transdermal administration of 17β Estradiol on postmenopausal bone loss: A two year prospective study. Obstet Gynecol. 1990;428S-465S. (April Suppl).
11. Stampfer MJ, Colditz GA, Willot WC. A prospective study of postmenopausal estrogen replacement therapy and cardiovascular disease: A 10 year follow-up from the Nurse's Study. N Eng J Med. 325:1991;756-762.
12. Hilditch JR, Lewis JE, Peter A, et al. A menopause-specific quality of life questionnaire: Development and psychometric properties. Maturitas. 24:1996;161-175.
13. 23rd edition Compendium of Pharmaceutical Specialities. 1989;Canadian Pharmaceutical Manufacturers' Association, Ottawa, Canada.
14. Sarason IG, Johnson JH, Siegel JM. Assessing the impact of life changes: development of the life experiences survey. J Cons Clin Psych. 46:(5):1978;932-946.
15. Likert RA. A technique for the development of attitude scales. Educ Psychol Measurement. 12:1952;313-315.
16. Hagen C, Christensen S, Christiansen C, Stockland K-E, Transbol I. Effect of two years' estrogen-gestagen replacement on climacteric symptoms and gonadotropins in the early postmenopausal period. Acta Obstet Gynecol Scand. 61:1982;237-241.
17. Steingold KA, Laufer L, Chetkowski RJ, et al. Treatment of hot flashes with transdermal estradiol administration. J Clin Endocrinol Metab. 61:1985;627-632.
18. Furuhjelm M, Karlgren E, Carlström K. The effect of estrogen therapy on somatic and psychical symptoms in postmenopausal women. Acta Obstet Gynecol Scand. 63:1984;655-661.
19. Iatrakis G, Haronis N, Sakellaropoulos G, Kourkoubas A, Gallos M. Psychosomatic symptoms of postmenopausal women with or without hormone treatment. Psychother Psychosom. 46:1986;116-121.
20. Erkkola R, Holma P, Järvi T, et al. Transdermal estrogen replacement therapy in a Finnish population. Maturitas. 13:1991;275-281.
21. Wiklund I, Karlberg J, Mattsson LA. Quality of life of postmenopausal women on a regimen of transdermal estradiol therapy: a double-blind placebo-controlled study. Am J Obstet Gynecol. 168:1993;824-830.
22. Wiklund I, Berg G, Hammar M, Karlberg J, Lindgren R, Sandin K. Long-term effect of transdermal hormonal therapy on aspects of quality of life in postmenopausal women. Maturitas. 14:1992;225-236.
23. Limouzin-Lamothe M, Mairon N, Joyce CRB, LeGal M. Quality of life after the menopause: Influence of hormonal replacement therapy. Am J Obstet Gynecol. 170:1994;618-624.
24. Jaszmann LJB. Campbell S. Epidemiology of the climacteric syndrome in the management of the menopause and postmenopause years. 1976;MTP Press, Lancaster.
25. McKinlay S, Brambilla D, Posner JG. The normal menopause transition. Maturitas. 14:1992;103-115.